These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 29686686)

  • 41. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complete CD95/FAS deficiency due to complex homozygous germline TNFRSF6 mutations in an adult patient with mild autoimmune lymphoproliferative syndrome (ALPS).
    Tessarin G; Mazza C; Baronio M; Gazzurelli L; Rossi S; Moratto D; Badolato R; Rensing-Ehl A; Ehl S; Warnatz K; Rosanelli C; Morello E; Plebani A; Lougaris V
    Clin Immunol; 2021 Jul; 228():108757. PubMed ID: 33992756
    [No Abstract]   [Full Text] [Related]  

  • 43. CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.
    Baecher-Allan CM; Costantino CM; Cvetanovich GL; Ashley CW; Beriou G; Dominguez-Villar M; Hafler DA
    J Immunol; 2011 Mar; 186(6):3317-26. PubMed ID: 21300823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection.
    Nomura K; Kanegane H; Otsubo K; Wakiguchi H; Noda Y; Kasahara Y; Miyawaki T
    Int J Hematol; 2011 Jun; 93(6):760-764. PubMed ID: 21626105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
    Sahin E; Sahin M
    J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects.
    Cagdas D; Halaçlı SO; Tan Ç; Lo B; Çetinkaya PG; Esenboğa S; Karaatmaca B; Matthews H; Balcı-Hayta B; Arıkoğlu T; Ezgü F; Aladağ E; Saltık-Temizel İN; Demir H; Kuşkonmaz B; Okur V; Gümrük F; Göker H; Çetinkaya D; Boztuğ K; Lenardo M; Sanal Ö; Tezcan İ
    J Clin Immunol; 2019 Oct; 39(7):726-738. PubMed ID: 31432443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human CD4
    Brown ME; Peters LD; Hanbali SR; Arnoletti JM; Sachs LK; Nguyen KQ; Carpenter EB; Seay HR; Fuhrman CA; Posgai AL; Shapiro MR; Brusko TM
    Front Immunol; 2022; 13():873560. PubMed ID: 35693814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired function of regulatory T-cells in patients with chronic obstructive pulmonary disease (COPD).
    Tan DB; Fernandez S; Price P; French MA; Thompson PJ; Moodley YP
    Immunobiology; 2014 Dec; 219(12):975-9. PubMed ID: 25097153
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multiple sclerosis patients have reduced resting and increased activated CD4
    Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
    Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
    Yang HX; Zhang W; Zhao LD; Li Y; Zhang FC; Tang FL; He W; Zhang X
    Arthritis Res Ther; 2009; 11(5):R153. PubMed ID: 19821980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
    Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory T Cells Increase After rh-MOG Stimulation in Non-Relapsing but Decrease in Relapsing MOG Antibody-Associated Disease at Onset in Children.
    Horellou P; de Chalus A; Giorgi L; Leroy C; Chrétien P; Hacein-Bey-Abina S; Bourgeois C; Mariette X; Serguera C; Le Grand R; Deiva K
    Front Immunol; 2021; 12():679770. PubMed ID: 34220827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DR(high+)CD45RA(-)-Tregs potentially affect the suppressive activity of the total Treg pool in renal transplant patients.
    Schaier M; Seissler N; Schmitt E; Meuer S; Hug F; Zeier M; Steinborn A
    PLoS One; 2012; 7(3):e34208. PubMed ID: 22470536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review.
    Hafezi N; Zaki-Dizaji M; Nirouei M; Asadi G; Sharifinejad N; Jamee M; Erfan Rasouli S; Hamedifar H; Sabzevari A; Chavoshzadeh Z; Yazdani R; Abolhassani H; Aghamohammadi A; Azizi G
    Pediatr Allergy Immunol; 2021 Oct; 32(7):1519-1532. PubMed ID: 33963613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
    Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
    Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
    Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
    Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.
    Baraut J; Grigore EI; Jean-Louis F; Khelifa SH; Durand C; Verrecchia F; Farge D; Michel L
    Bone Marrow Transplant; 2014 Mar; 49(3):349-54. PubMed ID: 24362364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
    McClymont SA; Putnam AL; Lee MR; Esensten JH; Liu W; Hulme MA; Hoffmüller U; Baron U; Olek S; Bluestone JA; Brusko TM
    J Immunol; 2011 Apr; 186(7):3918-26. PubMed ID: 21368230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.